NASDAQ:TMDITitan Medical Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Titan Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.92 +0.01 (+1.10 %) (As of 07/31/2020 04:00 PM ET) Add Compare Share Today's Range$0.87Now: $0.92▼$0.9450-Day Range$0.77MA: $0.93▼$1.1852-Week Range$0.12Now: $0.92▼$2.71Volume840,426 shsAverage Volume1.63 million shsMarket Capitalization$61.12 millionP/E Ratio2.00Dividend YieldN/ABeta3.24 ProfileAnalyst RatingsAdvanced ChartCompetitorsEarningsInstitutional OwnershipHeadlinesSocial Media Titan Medical Inc., a research and development stage company, focuses on the design, development, and commercialization of computer-assisted robotic surgical technologies for application in minimally invasive surgery (MIS). The company is developing the SPORT Surgical System, a single-port robotic surgical system that comprises a surgeon-controlled patient cart, which includes a 3D vision system and multi-articulating instruments for performing MIS procedures; and a surgeon workstation that provides the surgeon with ergonomic interface to the patient cart and a 3D endoscopic view inside the patient's body during MIS procedures. The SPORT Surgical System enables surgeons to perform surgical procedures for gynecologic, urologic, colorectal, and general abdominal indications. Titan Medical Inc. is headquartered in Toronto, Canada.Read More Beat the Market (BTM) Rank™ 3.3 Analyst's Opinion Consensus RatingTitan Medical has received a consensus rating of Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $1.25, Titan Medical has a potential upside of 35.9% from its current price of $0.92.Amount of Analyst CoverageTitan Medical has received no research coverage in the past 90 days. Previous Next 2.4 Community Rank Outperform VotesTitan Medical has received 140 “outperform” votes. (Add your “outperform” vote.)Underperform VotesTitan Medical has received 148 “underperform” votes. (Add your “underperform” vote.)Community SentimentTitan Medical has received 51.39% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Titan Medical and other stocks. Vote “Outperform” if you believe TMDI will outperform the S&P 500 over the long term. Vote “Underperform” if you believe TMDI will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldTitan Medical does not currently pay a dividend.Dividend GrowthTitan Medical does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Titan Medical insiders have not sold or bought any company stock.Percentage Held by InstitutionsOnly 3.41% of the stock of Titan Medical is held by institutions. Previous Next 1.3 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Titan Medical is 2.00, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 18.07.Price to Earnings Ratio vs. SectorThe P/E ratio of Titan Medical is 2.00, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 26.33. Previous Next Analyst Opinion: 3.3Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.38 out of 5 stars Industry, Sector and Symbol Stock Exchange NASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:TMDI Previous Symbol CUSIPN/A CIKN/A Webwww.titanmedicalinc.com Phone416-548-7522Debt Debt-to-Equity RatioN/A Current Ratio0.20 Quick Ratio0.20Price-To-Earnings Trailing P/E Ratio2.00 Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($0.29) per share Price / Book-3.17Profitability EPS (Most Recent Fiscal Year)N/A Net Income$-41,910,000.00 Net MarginsN/A Return on EquityN/A Return on Assets-195.16%Miscellaneous Employees9 Outstanding Shares66,430,000Market Cap$61.12 million Next Earnings Date8/5/2020 (Estimated) OptionableNot Optionable $0.92 +0.01 (+1.10 %) (As of 07/31/2020 04:00 PM ET) 30 days | 90 days | 365 days | Advanced Chart Receive TMDI News and Ratings via Email Sign-up to receive the latest news and ratings for TMDI and its competitors with MarketBeat's FREE daily newsletter. Titan Medical (NASDAQ:TMDI) Frequently Asked Questions How has Titan Medical's stock been impacted by COVID-19 (Coronavirus)? Titan Medical's stock was trading at $0.20 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, TMDI shares have increased by 360.0% and is now trading at $0.92. View which stocks have been most impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of Titan Medical? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Titan Medical in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Titan Medical. When is Titan Medical's next earnings date? Titan Medical is scheduled to release its next quarterly earnings announcement on Wednesday, August 5th 2020. View our earnings forecast for Titan Medical. How were Titan Medical's earnings last quarter? Titan Medical Inc. (NASDAQ:TMDI) released its earnings results on Wednesday, May, 13th. The company reported ($0.05) earnings per share (EPS) for the quarter. View Titan Medical's earnings history. What price target have analysts set for TMDI? 2 brokers have issued 12-month target prices for Titan Medical's stock. Their forecasts range from $1.00 to $1.50. On average, they anticipate Titan Medical's stock price to reach $1.25 in the next year. This suggests a possible upside of 35.9% from the stock's current price. View analysts' price targets for Titan Medical. Has Titan Medical been receiving favorable news coverage? News coverage about TMDI stock has trended negative on Monday, InfoTrie Sentiment Analysis reports. InfoTrie identifies negative and positive press coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Titan Medical earned a media sentiment score of -2.2 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View the latest news about Titan Medical. Are investors shorting Titan Medical? Titan Medical saw a drop in short interest in July. As of July 15th, there was short interest totaling 966,500 shares, a drop of 22.1% from the June 30th total of 1,240,000 shares. Based on an average trading volume of 4,190,000 shares, the days-to-cover ratio is presently 0.2 days. Currently, 1.6% of the company's stock are sold short. View Titan Medical's Current Options Chain. Who are some of Titan Medical's key competitors? Some companies that are related to Titan Medical include Repare Therapeutics (PYPD), Pulse Biosciences (PLSE), iCAD (ICAD), Westaim (WEDXF), Accuray (ARAY), T2 Biosystems (TTOO), Lyra Therapeutics (LYRA), Liquidia Technologies (LQDA), Apyx Medical (APYX), TELA Bio (TELA), Restoration Robotics (HAIR), Soliton (SOLY), BeyondAirInc . (XAIR), PAVmed (PAVM) and Venus Concept (VERO). View all competitors. What other stocks do shareholders of Titan Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Titan Medical investors own include NovaBay Pharmaceuticals (NBY), Alibaba Group (BABA), Micron Technology (MU), AcelRx Pharmaceuticals (ACRX), British American Tobacco (BTI), Inovio Pharmaceuticals (INO), Titan Pharmaceuticals (TTNP), Catalyst Biosciences (CBIO), Corbus Pharmaceuticals (CRBP) and Crispr Therapeutics (CRSP). Who are Titan Medical's key executives? Titan Medical's management team includes the following people: Mr. David J. McNally, Pres, CEO & Director (Age 57)Mr. Stephen D. Randall, CFO, Sec. & DirectorDr. Perry A. Genova, Sr. VP of R&DMr. Curtis R. Jensen, VP of Quality & Regulatory AffairsMr. Sachin A. Sankholkar, VP of Marketing What is Titan Medical's stock symbol? Titan Medical trades on the NASDAQ under the ticker symbol "TMDI." Who are Titan Medical's major shareholders? Titan Medical's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Accredited Investors Inc. (0.25%), MAI Capital Management (0.08%) and Valeo Financial Advisors LLC (0.08%). Which major investors are buying Titan Medical stock? TMDI stock was purchased by a variety of institutional investors in the last quarter, including Accredited Investors Inc., MAI Capital Management, and Valeo Financial Advisors LLC. How do I buy shares of Titan Medical? Shares of TMDI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Titan Medical's stock price today? One share of TMDI stock can currently be purchased for approximately $0.92. How big of a company is Titan Medical? Titan Medical has a market capitalization of $61.12 million. Titan Medical employs 9 workers across the globe. What is Titan Medical's official website? The official website for Titan Medical is www.titanmedicalinc.com. How can I contact Titan Medical? Titan Medical's mailing address is 155 UNIVERSITY AVENUE, TORONTO A6, M5H 3B7. The company can be reached via phone at 416-548-7522. This page was last updated on 8/3/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
